$19.61
1.87% day before yesterday
Nasdaq, Jun 12, 10:00 pm CET
ISIN
GB00BY2Z0H74
Symbol
PRTC
Sector
Industry

PureTech Health Plc - ADR Stock price

$19.61
+2.61 15.35% 1M
-0.74 3.64% 6M
+1.15 6.23% YTD
-10.19 34.19% 1Y
-18.89 49.06% 5Y
-18.89 49.06% 10Y
-18.89 49.06% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
+0.00 0.00%
ISIN
GB00BY2Z0H74
Symbol
PRTC
Sector
Industry

Key metrics

Market capitalization $472.30m
Enterprise Value $114.33m
P/E (TTM) P/E ratio 103.21
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 23.67
P/S ratio (TTM) P/S ratio 97.78
P/B ratio (TTM) P/B ratio 11.32
Revenue growth (TTM) Revenue growth 45.05%
Revenue (TTM) Revenue $4.83m
EBIT (operating result TTM) EBIT $-136.10m
Free Cash Flow (TTM) Free Cash Flow $-134.38m
Cash position $380.33m
EPS (TTM) EPS $0.19
P/E forward negative
P/S forward 8.70
EV/Sales forward 2.11
Short interest 0.05%
Show more

Is PureTech Health Plc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

PureTech Health Plc - ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a PureTech Health Plc - ADR forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a PureTech Health Plc - ADR forecast:

Buy
100%

Financial data from PureTech Health Plc - ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
4.83 4.83
45% 45%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 71 71
34% 34%
1,480%
- Research and Development Expense 69 69
28% 28%
1,438%
-133 -133
6% 6%
-2,744%
- Depreciation and Amortization 3.57 3.57
28% 28%
74%
EBIT (Operating Income) EBIT -136 -136
7% 7%
-2,818%
Net Profit 54 54
181% 181%
1,108%

In millions USD.

Don't miss a Thing! We will send you all news about PureTech Health Plc - ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

PureTech Health Plc - ADR Stock News

Neutral
Business Wire
23 days ago
BOSTON--(BUSINESS WIRE)--PureTech to Present at the Jefferies Global Healthcare Conference.
Neutral
Business Wire
about one month ago
BOSTON--(BUSINESS WIRE)--PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF).
Neutral
Business Wire
about one month ago
BOSTON--(BUSINESS WIRE)--PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference.
More PureTech Health Plc - ADR News

Company Profile

PureTech Health Plc is a cross-disciplinary bio-pharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune. It operates through the following segments: Internal, and Affiliates. The Internal segment is advancing a pipeline fuelled by recent discoveries in lymphatics and immune cell trafficking to modulate disease in a tissue-specific manner. The Affiliates segment is comprised of the programmes within PureTech's Affiliates division. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.

Head office United Kingdom
CEO Bharatt Chowrira
Employees 90
Founded 2015
Website puretechhealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today